variant
acthsecret
pituitari
cell
line
isol
make
acth
sulfat
protein
characterist
regul
secretori
pathway
densecor
secretori
granul
retain
constitut
secret
unlik
wild
type
cell
variant
store
releas
stimul
free
glycosaminoglycan
gag
chain
addit
variant
cell
store
trypsinogen
proinsulin
protein
target
dens
core
secretori
granul
wild
type
cell
regul
pathway
could
restor
transfect
dna
encod
trypsinogen
solubl
regul
secretori
protein
target
secretori
granul
comparison
secret
variant
wild
type
cell
allow
distinct
made
constitut
secret
basal
secret
spontan
releas
regul
protein
occur
absenc
stimul
materi
method
synthet
dna
linker
restrict
endonucleas
polynucleotid
kinas
new
england
biolab
beverli
dna
polymeras
klenow
dna
ligas
boehring
mannheim
biochem
indianapoli
cystein
sulfat
amersham
corp
arlington
height
il
tran
label
icn
radiochem
irvin
ca
use
tracer
acth
ria
obtain
metabol
research
lab
univ
cell
special
regul
secretori
vesicl
call
secretori
granul
sort
regul
secretori
product
away
constitut
secret
product
lysosom
enzym
occur
transgolgi
network
griffith
simon
tooz
et
al
orci
et
al
concentr
content
secretori
granul
releas
cell
respons
extern
signal
wherea
signal
requir
constitut
secret
mechan
protein
sort
two
secretori
pathway
known
hormonespecif
receptor
mechan
chung
et
al
select
condens
secretori
granul
content
kelli
gerd
et
al
propos
analysi
secretori
process
made
easier
secretiondefect
mutant
avail
step
involv
constitut
secret
elucid
yeast
use
temperaturesensit
secret
mutant
novick
et
al
schekman
mammalian
cell
mutant
describ
influenc
secret
mutat
involv
chang
structur
secretori
protein
chang
posttransl
modif
review
see
tartakoff
mani
exampl
defect
secret
involv
protein
constitut
secret
immunoglobulin
chain
review
see
scharff
et
al
viral
glycoprotein
tufaro
et
al
mutat
machineri
constitut
secret
often
lethal
sinc
constitut
pathway
respons
normal
membran
traffic
vital
cell
growth
nonleth
mutat
affect
regul
secretori
process
report
ciliat
protozoa
exampl
exocytosi
trichocyst
paramecium
aufderheid
leforttran
et
al
mucocyst
tetrahymena
oria
et
al
maihl
satir
paper
describ
mammalian
cell
variant
lost
capac
regul
secret
mous
pituitari
cell
line
express
hormon
acth
packag
electrondens
secretori
granul
main
eipper
addit
regul
secret
acth
cell
secret
protein
laminin
constitut
secretori
pathway
burgess
et
al
paper
character
variant
cell
express
sever
solubl
marker
dens
core
secretori
vesicl
includ
acth
morpholog
identifi
dens
core
secretori
granul
abl
experiment
distinguish
endocrin
cell
two
type
unstimul
secret
basal
releas
constitut
secret
earlier
estim
effici
sort
cell
ignor
basal
secret
measur
sort
regul
pathway
moor
kelli
secret
properti
variant
cell
line
indic
consider
fraction
protein
sort
regul
pathway
secret
absenc
stimul
term
basal
secret
myeloma
deriv
marguli
et
al
resist
mm
ouabain
ttgmi
sensit
hat
medium
ttm
hypoxanthin
thymidin
aminopterin
origin
deriv
dr
matthew
scbatff
albert
einstein
colleg
medicin
bronx
ny
obtain
dr
sheri
l
morrison
univers
california
lo
angel
ca
cell
grown
dme
g
glucoselit
supplement
fc
hyclon
laboratori
logan
ut
penicillinstreptomycin
kept
atmospher
cell
describ
main
eipper
gumbin
kelli
cell
sabol
laurel
thoma
oregon
health
scienc
univers
portland
cell
grown
dme
contain
fc
penicillinstreptomycin
kept
atmospher
cell
wt
cell
prsv
trypsinogen
express
vector
describ
previous
burgess
et
al
express
vector
contain
genom
clone
carri
endogen
polyadenyl
signal
construct
deriv
rsvltr
plasmid
contain
chloramphenicol
acetyltransferas
cat
gene
gorman
et
al
vector
cat
gene
remov
replac
either
barn
hi
hind
iii
site
use
dna
linker
k
kelley
et
al
contain
barn
hi
fragment
entir
rearrang
mous
ig
chain
genom
clone
myeloma
laskov
scharff
obtain
dr
brain
van
ness
univers
iowa
iowa
citi
io
k
chain
genom
clone
cleav
pvu
ii
remov
unwant
sequenc
brought
start
site
kappa
chain
gene
within
bp
end
dna
fragment
truncat
pvu
iibam
hi
fragment
adapt
barn
hi
linker
clone
rsvltrcontain
express
vector
barn
hi
site
proinsulin
laub
rntter
obtain
dr
michael
walker
dr
william
j
rutter
univers
california
san
francisco
ca
proinsulin
gene
contain
plasmid
chimera
edna
end
genom
sequenc
carri
endogen
polyadenyl
signal
proinsulin
gene
eco
ri
fragment
remov
clone
rsvcontain
express
vector
use
hind
hi
linker
larg
scale
plasmid
prep
isol
bacteri
cell
clear
lysat
techniqu
clewel
helinski
plasmid
purifi
two
equilibrium
gradient
cesium
chlorid
use
standard
procedur
maniati
et
al
dna
transfect
cell
calcium
phosphat
precipit
protocol
moor
et
al
stabl
transform
ttg
wt
variou
plasmid
dna
tg
select
dna
southern
berg
ptkhygromycin
resist
plasmid
dr
dan
littman
univers
california
san
francisco
ca
mix
appli
calcium
abbrevi
use
paper
cat
chioramphenicol
acetyltransferas
gag
glycosaminoglycan
peg
polyethylen
glycol
sac
cowan
strain
bacteri
cell
phosphat
precipit
dish
cellsdish
cell
stabl
clone
select
either
mgml
mgmi
wt
antibiot
geneticin
gibco
laboratori
grand
island
ny
mgml
hygromycin
boehring
mannheim
biochem
drugresist
clone
screen
product
desir
protein
metabol
label
follow
immunoprecipit
cell
extract
cultur
media
appropri
antibodi
fix
protein
acontain
bacteri
cell
immunoprecipit
analyz
sdspage
follow
autoradiographi
transfect
wild
type
cell
express
trypsinogen
describ
burgess
et
al
wt
ceil
express
proinsulin
gener
dr
sam
green
univers
california
san
francisco
ca
use
human
proinsulincontain
express
vector
describ
variant
cell
isol
slow
grow
clone
surviv
sever
round
drug
select
somat
cell
hybrid
procedur
kohler
milstein
marguli
et
al
ceil
hat
resist
ouabain
sensit
mous
myeloma
hat
sensit
ouabain
resist
equal
number
cell
type
mix
suspens
centrifug
low
speed
g
form
pellet
cell
resuspend
serumfre
dme
contain
polyethylen
glycol
peg
ph
incub
immedi
dilut
mi
fresh
medium
cell
remov
peg
lowspe
centrifug
resuspend
dme
contain
fc
hat
mm
oubain
select
medium
chang
everi
h
cell
kill
slower
grow
clone
exhibit
qualiti
describ
result
recov
subclon
addit
time
ensur
homogen
sulfat
protein
label
incub
cell
h
normal
growth
condit
sulfatedeplet
dme
conrain
mci
sulfat
penicillin
streptomycin
glutamin
dialyz
fc
describ
moor
et
al
cell
incub
serumfre
dme
two
interv
latter
interv
presenc
absenc
mm
sampl
precipit
cold
tca
contain
mgml
deoxychol
wash
twice
cold
aceton
redissolv
sdspage
sampl
buffer
analysi
perform
polyacrylamid
gradient
gel
soak
sodium
salicyl
contain
methanol
dri
expos
film
eastman
kodak
co
rochest
ny
sulfat
free
gag
chain
gener
describ
burgess
kelli
preincub
cell
h
dme
growth
medium
contain
mm
vxylosid
incub
cell
sulfatedeplet
dme
contain
xylosid
rnci
sulfat
cell
chase
incub
h
serumfre
medium
contain
xylosid
medium
collect
analyz
directli
polyacrylamid
gel
process
autoradiographi
describ
pulsechas
experi
follow
free
gag
chain
perform
prepar
confluent
sixwel
dish
well
preincob
h
dme
contain
mm
xylosid
shorten
label
time
mci
sulfat
h
wash
cell
pb
incub
rain
complet
growth
medium
min
chase
mm
ad
one
well
ceil
media
collect
rain
rain
cbase
camp
ad
second
media
collect
rain
end
chase
interv
media
remov
cell
dialyz
h
three
chang
mm
dri
speed
vac
savant
instrument
hicksviil
ny
h
dissolv
sdspage
sampl
buffer
analyz
polyacrylamid
gel
describ
cell
extract
prepar
direct
lysi
ndet
buffer
deoxychol
mm
edta
mm
tri
ph
burgess
et
al
remov
nuclei
ad
sdspage
sampl
buffer
load
portion
directli
polyacrylamid
gel
gag
chain
quantif
cut
part
gel
contain
gag
chain
dissolv
nc
tissuehomngen
solut
amersbam
corp
tissu
solubil
research
product
intern
corp
mt
prospect
il
count
liquid
scintil
counter
screen
transfect
clone
cell
product
trypsinogen
ig
light
chain
lff
lo
cell
incub
h
dme
lack
methionin
cystein
supplement
fc
either
methionin
cystein
han
label
cultur
media
cell
extract
recov
adjust
final
concentr
sd
ndet
sampl
preclear
incub
min
room
temperatur
pl
prewash
sac
pansorbin
zysorbin
materi
nonspeeit
bound
sac
remov
centrifug
sampl
incub
h
specif
antiserum
either
rabbit
antimous
rabbit
antirat
trypsinogen
amount
type
antiserum
use
immunoprecipit
optim
use
deriv
mous
myeloma
express
k
light
chain
transfect
wild
type
cell
express
trypsinogen
baumal
et
al
burgess
et
al
solubl
immunoprecipit
recov
incub
fix
sac
min
room
temperatur
prepar
sampl
analysi
sdspage
autoradiographi
describ
burgess
et
al
examin
secret
protein
medium
stimul
secretagogu
cell
treat
describ
burgess
et
al
burgess
et
al
trypsinogenexpress
wild
type
ceil
variant
cell
incub
first
h
deplet
dme
contain
ci
lzss
cystein
fc
glutamin
penicillin
streptomycin
volum
complet
medium
interv
fresh
label
medium
contain
cystein
specif
activ
label
period
cell
wash
twice
pb
chase
normal
media
three
interv
third
interv
one
portion
ceil
incub
presenc
mm
stimul
releas
regul
secretori
pathway
media
cell
extract
collect
time
interv
immunoprecipit
rabbit
antitrypsinogen
antiproinsniin
antikappa
antiserum
describ
immunoprecipit
analyz
sdspage
gel
amount
rnateri
secret
quantifi
cut
band
gel
flute
label
protein
tissuesolubil
solut
h
count
liquid
scintil
counter
scan
autoradiograph
gel
soft
laser
densitomet
lkb
instrument
inc
bromma
sweden
proinsulin
secret
examin
essenti
procedur
except
immunoprecipit
wash
distil
water
remov
deterg
analyz
gradient
sdspage
gel
ident
proinsulin
matur
process
insulin
band
distinguish
gel
molecular
weight
use
two
antiserum
rabbit
antihuman
c
peptid
recogn
proinsniin
guinea
pig
antimatur
insulin
recogn
form
chain
secret
transfect
cell
determin
describ
trypsinogen
except
tci
methionin
use
label
cell
chase
two
interv
latter
interv
presenc
absenc
amount
endogen
hormon
acth
releas
media
stimul
interv
determin
solidphas
acth
radioimmunoassay
previous
describ
moor
et
al
protein
determin
assay
amido
schwartz
dyebind
assay
moor
et
al
synaptophysin
detect
immunoprecipit
cell
extract
label
h
tran
label
either
rabbit
antirat
synapt
vesicl
antiserum
cutler
cramer
recogn
synaptophysin
preimmun
serum
follow
sac
antiacth
immunofluoresc
perform
describ
matsuuchi
et
al
cell
grown
polydlysineco
glass
coverslip
incub
rabbit
antiacth
antibodi
sheep
antirabbit
igg
coupl
fluorescein
cappel
laboratori
cochranvil
pa
antisynaptophysin
immunofluoresc
done
fix
triton
permeabil
cell
monoclon
antibodi
boehring
mannheim
biochem
dilut
follow
fluoresceincoupl
goat
antimous
dilut
describ
matsunchi
et
al
em
perform
describ
matsuuchi
et
al
attempt
gener
antibodysecret
endocrin
cell
mous
pituitari
cell
line
ouabain
sensit
hat
resist
fuse
mous
plasmacytoma
ouabain
resist
hat
sensit
clone
select
surviv
sever
round
select
medium
contain
ouabain
mm
hat
surviv
clone
differ
wild
type
cell
grew
slowli
extend
thin
branch
process
sever
cell
bodi
length
individu
subclon
test
immunofluoresc
fixat
deterg
permeabil
cell
express
endogen
hormon
express
cell
acth
metabol
label
clone
also
test
immunoprecipit
express
antibodi
produc
plasmacytoma
x
subclon
recov
none
express
antibodi
express
acth
two
mix
contain
acth
express
nonexpress
ceil
one
appear
acth
nonexpressor
none
subclon
retain
ouabain
resist
myeloma
parent
acth
nonexpressor
subclon
two
addit
time
ensur
cell
cultur
express
acth
character
sibl
clone
cell
express
acth
also
isol
subclon
use
atchexpress
control
cell
cell
normal
extend
process
plate
glass
plastic
substrat
process
enhanc
incub
cell
growth
medium
contain
mm
burgess
kelli
cell
plate
glass
coverslip
howev
extend
long
thin
process
without
stimul
secretagogu
acth
could
detect
immunofluoresc
cell
cell
fig
sensit
radioimmunoassay
use
detect
acth
cell
extract
wild
type
cell
contain
ng
acth
g
cell
protein
cell
contain
ng
acth
g
cell
protein
ceil
contain
less
ng
acth
g
cell
protein
limit
detect
assay
least
less
wild
type
cell
normal
cell
acth
condens
packag
secretori
granul
electrondens
core
observ
electron
micrograph
see
dens
core
secretori
granul
present
absent
variant
cell
section
eponembed
cell
examin
electron
microscop
electron
micrograph
random
field
acthneg
acthposit
cell
taken
number
dens
core
granul
count
photo
acthposit
cell
contain
morpholog
identifi
dens
core
vesicl
contrast
photo
acthneg
cell
contain
one
dens
structur
could
dens
core
vesicl
variant
line
lost
regul
pathway
abl
store
secret
stimul
solubl
compon
dens
core
secretori
granul
includ
chromogranin
iacangelo
et
al
secretogranin
rosa
et
ai
sulfat
protein
moor
et
al
sulfat
staircas
repres
proteoglycan
sulfat
glycosaminoglycan
gag
side
chain
moor
et
al
burgess
kelli
mani
compon
express
variant
sulfat
proteoglycan
protein
sort
regul
secretori
pathway
releas
stimul
cell
contain
regul
secretori
pathway
fig
lane
made
releas
medium
variant
fig
lane
sulfat
materi
extract
cell
higher
molecular
weight
materi
enter
gel
materi
migrat
diffus
band
fig
lane
although
sulfat
materi
migrat
kd
could
seen
decreas
cell
extract
stimul
correspond
appear
stimul
medium
could
never
reproduc
detect
addit
neither
chromogranin
mrna
could
easili
detect
cell
express
low
level
grime
r
b
kelli
unpublish
result
although
dens
core
vesiclespecif
proteoglycan
sulfat
molecul
absent
variant
cell
machineri
synthes
glycosaminoglycan
side
chain
proteoglycan
still
intact
shown
preincub
cell
medium
contain
mm
xylosid
label
cell
continu
presenc
xylosid
sulfat
xylosid
compet
protein
core
proteoglycan
attach
free
gag
chain
free
gag
chain
xylosid
conjug
cell
extract
media
recov
analyz
sdspolyacrylamid
gel
wild
type
cell
grown
xylosid
analogu
secret
medium
ladder
gag
chain
migrat
protein
molecular
weight
marker
kd
fig
b
lane
variant
cell
grown
condit
secret
ladder
sulfat
gag
chain
roughli
molecular
weight
although
ladder
less
discret
fig
b
lane
test
possibl
secretori
granul
present
variant
lack
identifi
marker
storag
releas
free
gag
chain
use
nonspecif
granul
content
marker
earlier
work
gag
chain
appear
segreg
bulk
phase
marker
regul
constitut
pathway
burgess
kelli
measur
gag
storag
releas
regu
min
secret
e
intraceuular
zx
gag
chain
recov
sdspolyacrylamid
dissolv
gel
tissu
solubil
quantifi
liquid
scintiuat
count
c
wild
type
c
variant
ceil
puls
chase
describ
b
taken
min
chase
either
stimul
secret
gag
chain
mm
gag
chain
secret
media
recov
either
rain
chase
addit
rain
chase
addit
n
without
camp
camp
late
pathway
wild
type
ceil
label
sulfat
chase
vari
length
time
gag
identifi
gel
electrophoresi
ladder
radioact
materi
migrat
protein
molecular
weight
kd
fig
b
wild
type
cell
gag
secret
medium
half
time
min
remaind
gag
store
intracellularli
fig
chase
period
treatment
increas
amount
gag
chain
releas
media
twofold
suggest
gag
inde
store
regul
secretori
pathway
fig
c
contrast
variant
cell
releas
gag
chain
halftim
also
min
fig
b
stimul
secret
remain
gag
chain
could
seen
addit
fig
longer
incub
time
cell
xylosid
sulfat
extens
label
store
pool
gag
chain
wild
type
cell
sinc
halftim
longer
hour
evid
storag
gag
chain
regul
releas
could
detect
variant
cell
even
condit
wild
type
cell
twenti
time
effici
store
gag
variant
gag
store
effici
trypsinogen
acth
insulin
either
variant
secretori
granul
gag
may
flow
gag
could
enter
granul
miss
compon
sort
machineri
appar
effici
sort
gag
chain
regul
pathway
consist
earlier
assumpt
burgess
kelli
use
bulk
phase
marker
empti
secretori
granul
membran
present
variant
cell
absenc
dens
core
lack
specif
content
oppos
free
gag
chain
packag
membran
secretori
granul
might
induc
variant
introduc
protein
normaili
packag
vesicl
regul
pathway
test
possibl
trypsinogen
protein
sort
regul
granul
express
variant
cell
dnamedi
transfect
trypsinogen
target
transfect
wild
type
cell
regul
secretori
compart
hous
endocrin
hormon
acth
insulin
burgess
et
al
burgess
et
al
orci
et
al
test
format
regul
pathway
trypsinogen
transfect
variant
cell
label
h
medium
contain
methionin
cystein
chase
sever
interv
stimul
releas
label
materi
regul
pathway
moor
kelli
burgess
et
al
agreement
previou
report
trypsinogen
secret
wild
type
cell
characterist
regul
secretori
pathway
burgess
et
al
moor
et
al
slow
releas
label
trypsinogen
absenc
stimul
total
label
trypsinogen
releas
first
chase
period
secret
rate
fell
half
time
h
increas
releas
trypsinogen
obtain
secretagogu
present
last
chase
period
fig
contrast
trypsinogen
secret
variant
much
rapid
trypsinogen
releas
first
chase
interv
consist
half
time
secret
rain
amount
trypsinogen
secret
increas
exposur
fig
b
express
regul
secretori
protein
trypsinogen
variant
cell
therefor
induc
format
regul
secretori
pathway
reveal
presenc
empti
secretori
granul
lack
content
protein
unstimul
releas
trypsinogen
variant
correspond
half
time
secret
min
consider
faster
unstimul
releas
wild
type
h
rate
trypsinogen
releas
unstimul
variant
cell
compar
rate
constitut
secret
immunoglobulin
chain
wild
type
cell
plasma
cell
secret
antibodi
shown
constitut
evid
storag
stimul
releas
tartakoff
vassal
tartakoff
et
al
antibodi
conveni
constitut
secretori
protein
studi
gene
immunoglobulin
heavi
light
chain
express
mani
plasma
cell
tumor
line
clone
cell
line
particular
interest
plasmacytoma
express
heavi
chain
r
light
chain
overexpress
latter
r
light
chain
assembl
heavi
chain
secret
freeli
medium
laskov
scharff
make
r
chain
good
candid
simpl
solubl
product
use
constitut
secretori
marker
nonlymphoid
cell
cell
cell
transfect
r
light
chain
gene
made
high
level
r
chain
secret
kinet
ident
immunoglobulin
secret
normal
plasma
cell
line
transfect
cell
label
r
light
chain
secret
first
chase
interv
half
time
secret
h
stimul
enhanc
amount
light
chain
secret
fig
sinc
transfect
trypsinogen
secret
variant
rate
indistinguish
constitut
secret
rlight
chain
transfect
wild
type
cell
fig
b
like
unstimul
secret
variant
constitut
secretori
pathway
constitut
secret
trypsinogen
r
chain
half
time
h
data
variant
show
slow
unstimul
releas
trypsinogen
wild
type
cell
fig
must
anoth
explan
one
possibl
unstimul
releas
wild
type
cell
due
entir
constitut
secret
also
basal
releas
basal
releas
secret
regul
pathway
absenc
prior
stimul
secretagogu
secret
prohormon
process
matur
form
sort
regul
pathway
orci
et
al
basal
releas
appear
unstimul
releas
matur
hormon
secret
insulin
form
examin
wild
type
cell
fig
c
matur
insulin
inde
releas
absenc
stimul
chase
rate
label
insulin
secret
drop
half
life
h
rate
proinsulin
secret
fell
half
time
rain
kinet
suggest
matur
insulin
releas
basal
secretori
granul
proinsulin
constitut
pathway
consist
explan
observ
wherea
exposur
increas
rate
insulin
secret
sevenfold
effect
rate
proinsulin
secret
proinsulintransfect
variant
cell
secret
proinsulin
neither
store
process
prohormon
matur
form
data
shown
comparison
variant
wild
type
cell
clearli
demonstr
therefor
two
form
unstimul
releas
constitut
basal
initi
experi
pathway
secretori
protein
sort
cell
regul
pathway
function
defin
secret
acth
hormon
respons
secretagogu
constitut
pathway
defin
extern
viral
membran
protein
requir
exposur
secretagogu
gumbin
kelli
unresolv
work
subsequ
studi
whether
constitut
secret
account
unstimul
releas
especi
slow
releas
observ
regul
protein
endogen
well
transfect
burgess
et
al
moor
kelli
variant
clearli
lack
regul
secretori
pathway
secret
cell
rapid
constitut
characterist
secret
variant
allow
us
propos
must
two
pathway
unstimul
releas
wild
type
cell
constitut
secret
describ
earlier
work
basal
releas
compart
come
sort
regul
pathway
sinc
regul
pathway
miss
variant
basal
releas
must
also
miss
basal
releas
may
fusion
matur
regul
secretori
granul
plasma
membran
absenc
stimul
bud
vesicl
immatur
granul
propos
yon
zastrow
et
al
whatev
mechan
basal
releas
account
larg
fraction
total
secret
protein
import
consequ
analysi
sort
neuroendocrin
cell
line
thu
measur
ratio
stimul
unstimul
releas
need
measur
sort
measur
fraction
materi
sort
regul
pathway
releas
stimul
secretagogu
furthermor
sort
index
use
moor
kelli
measur
protein
sort
effici
ignor
basal
releas
underestim
abil
cell
correctli
sort
protein
regul
pathway
basal
releas
endocrin
tissu
may
physiolog
relev
endocrin
cell
organ
basal
level
secret
respond
posit
neg
stimuli
rais
lower
hormon
level
blood
presenc
basal
secret
tumor
cell
line
perhap
properti
normal
cell
rather
aberr
control
regul
secretori
process
although
variant
recov
somat
cell
hybrid
cell
mous
myeloma
cell
unlik
repres
true
hybrid
cell
myeloma
cell
sinc
lack
properti
myeloma
parent
immunoglobulin
express
resist
oubain
marguli
et
al
contrast
variant
exhibit
mani
properti
parent
ceil
surviv
exposur
hat
medium
adher
extend
process
express
synaptophysin
data
shown
membran
protein
share
neuron
endocrin
cell
navon
et
al
john
et
al
frank
et
al
weideman
frank
variant
also
target
synaptophysin
made
synapt
vesiclelik
structur
data
shown
characterist
properti
neuroendocrin
cell
line
cliftogradi
et
al
subclon
retain
abil
express
acth
also
contain
dens
core
secretori
granul
retain
abil
releas
materi
regul
pathway
cell
surviv
drug
select
may
spontan
variant
resist
short
exposur
ouabaln
perhap
slow
growth
rate
variant
exhibit
multipl
defect
includ
loss
secretori
granul
electrondens
core
loss
sever
granul
content
protein
acth
sulfat
protein
granulespecif
sulfat
proteoglycan
variant
could
reflect
earli
development
state
express
secretori
granul
content
protein
switch
assum
express
granul
content
requir
dens
core
secretori
granul
format
determin
whether
absenc
dens
core
format
empti
secretori
granul
membran
still
form
capabl
store
releas
stimul
exocrin
protein
trypsinogen
sinc
regul
pathwaydefici
variant
could
store
free
gag
chain
storag
properti
releas
free
gag
chain
stimul
wild
type
cell
must
regul
pathway
wild
type
cell
almost
half
gag
chain
made
puls
remain
store
releas
compart
end
long
chase
fig
storag
gag
regul
secretori
pathway
surprisingli
high
effici
compar
found
acth
human
growth
hormon
moor
kelli
trypsinogen
burgess
et
al
insulin
kelli
et
al
appar
gag
chain
true
bulkphas
marker
propos
burgess
kelli
tripeptid
behav
bulkphas
marker
wieland
et
al
exclud
regul
secretori
pathway
insulinsecret
cell
gold
et
al
gag
may
sort
transgolgi
network
secretori
granul
either
gagspecif
receptor
similar
hormonespecif
receptor
chung
et
al
associ
protein
sort
latter
mechan
invok
explain
sort
antisecretogranin
antibodi
secretori
granul
altern
possibl
cell
machineri
synthes
sulfat
gag
chain
remain
activ
immatur
granul
protein
sort
event
occur
consist
altern
find
cell
sulfatedlabel
protein
oligosaccharid
appear
sort
effici
methionin
cysteinelabel
protein
matsuuchi
l
r
b
kelli
unpublish
resuit
preferenti
secret
parathyroid
tissu
sulfatelabel
chromogranin
also
seen
explain
propos
sulfat
occur
sort
chromogranin
secretori
granul
gorr
cohn
pulselabel
cell
contrast
sulfat
immatur
matur
secretori
granul
seen
tooz
huttner
resolv
point
similar
experi
need
done
wild
type
variant
cell
